EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Recovery of Recurrent Laryngeal Nerve Function With Neoadjuvant Treatment: Neural Characterization

Marika D Russell iD, Amr H Abdelhamid Ahmed iD, Zipei Feng, David C Shonka, Amanda S Karcioglu iD, Ayaka J Iwata, Natalia Kyriazidis, Sameer H Siddiqui, Tejas S Athni, Jong C Park, Lori J Wirth, Mark E Zafereo und 1 weitere

The Laryngoscope · 2024

DOI: 10.1002/lary.31304 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Laryngoscope, 2024. Verfasst von Marika D Russell und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thyroid and Parathyroid Endocrine Surgery, Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Harva…. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Recurrent Laryngeal Nerve, Recovery of Function, Vocal Cord Paralysis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Neoadjuvant targeted therapy has emerged as a promising treatment strategy for locally aggressive thyroid cancer. Its impact on tumor and adjacent tissues remains a nascent area of study. Here we report on a series of six subjects with locally advanced thyroid cancer and recurrent laryngeal nerve (RLN) paralysis who experienced recovery of RLN function with neoadjuvant treatment and describe the morphologic and electrophysiologic characteristics of these recovered nerves.

Methods

This is a multicenter retrospective review. Descriptive analysis was conducted to examine the following parameters for recovered nerves: (1) nerve morphology, characterized as Type A (involving epineurium only) versus Type B (extending beyond epineurium); (2) proximal stimulability (normal vs. abnormal vs. absent); and (3) surgical management (resection vs. preservation).

Results

Six subjects with unilateral VFP were identified. Median time to return of VF mobility was 3 months (range 2–13.5). All nerves (100%) were noted to have Type A morphology at surgery. Proximal stimulability was normal in four subjects (66.7%), abnormal in one (16.7%), and absent in one (16.7%). Nerves that had improvement of function through neoadjuvant therapy were able to be surgically preserved in five subjects (83.3%).

Conclusions

This represents the first characterization of RLNs that have recovered function with neoadjuvant treatment of locally advanced thyroid cancer. Although much remains unknown, our findings indicate carcinomatous neural invasion is a reversible process and recovered nerves may demonstrate normal morphology and electrophysiologic activity. Level of Evidence 4 Laryngoscope , 134:3415–3419, 2024

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyRecurrent Laryngeal NerveRecovery of FunctionVocal Cord ParalysisThyroid NeoplasmsHumansRetrospective StudiesMiddle AgedFemaleMaleAdultThyroidectomyAgedTreatment Outcome

Stichwörter der Autor:innen

neoadjuvantparalysisrecoveryrecurrent laryngeal nervesurgerythyroid

Autor:innen und Institutionen

  • Division of Thyroid and Parathyroid Endocrine Surgery, Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, U.S.A.
  • Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Stanford, California, U.S.A.
  • Department of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, U.S.A.
  • Department of Otolaryngology-Head and Neck Surgery, University of Virginia Health System, Charlottesville, Virginia, U.S.A.
  • Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, NorthShore University HealthSystem, Evanston, Illinois, U.S.A.
  • The University of Chicago, Pritzker School of Medicine, Chicago, Illinois, U.S.A.

ORCID-Profile: Marika D Russell, Amr H Abdelhamid Ahmed, Amanda S Karcioglu, Gregory W Randolph

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Russell, M. D., Abdelhamid Ahmed, A. H., Feng, Z., Shonka, D. C., Karcioglu, A. S., Iwata, A. J., Kyriazidis, N., Siddiqui, S. H., Athni, T. S., Park, J. C., Wirth, L. J., Zafereo, M. E., & Randolph, G. W. (2024). Recovery of Recurrent Laryngeal Nerve Function With Neoadjuvant Treatment: Neural Characterization. The Laryngoscope. https://doi.org/10.1002/lary.31304

Vancouver

Russell MD, Abdelhamid Ahmed AH, Feng Z, Shonka DC, Karcioglu AS, Iwata AJ, et al. Recovery of Recurrent Laryngeal Nerve Function With Neoadjuvant Treatment: Neural Characterization. The Laryngoscope. 2024. doi:10.1002/lary.31304

BibTeX
@article{Russell2024,
  author = {Russell, Marika D and Abdelhamid Ahmed, Amr H and Feng, Zipei and Shonka, David C and Karcioglu, Amanda S and Iwata, Ayaka J and Kyriazidis, Natalia and Siddiqui, Sameer H and Athni, Tejas S and Park, Jong C and Wirth, Lori J and Zafereo, Mark E and Randolph, Gregory W},
  title = {Recovery of Recurrent Laryngeal Nerve Function With Neoadjuvant Treatment: Neural Characterization},
  journal = {The Laryngoscope},
  year = {2024},
  doi = {10.1002/lary.31304}
}
Kostenlos starten →